Ravi Kumar Paluri

Also affiliated with Wake Forest University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Use of self-rated health to identify frailty and predict mortality in older adults with cancer. Results from the care study.”.

Use of self-rated health to identify frailty and predict mortality in older adults with cancer. Results from the care study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12046

N/A

0DataRank · unranked

10 citations

Smith Giri, Nabiel Mir, Kelly Kenzik, Andrew M. McDonald, Crystal Young Smith +5 more

Association between chronological age and geriatric assessment (GA) to identify deficits in elderly adults with cancer: Findings from the Care Registry.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12048

N/A

0DataRank · unranked

4 citations

Mustafa Al Obaidi, Alice N. Weaver, Kelly Kenzik, Andrew M. McDonald, Mackenzi Pergolotti +6 more

Geriatric assessment (GA) predictors of 1y mortality in older adults with gastrointestinal (GI) malignancies: Results from the CARE study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12047

N/A

0DataRank · unranked

0 citations

Chen Dai, Mustafa Al Obaidi, Smith Giri, Kelly Kenzik, Andrew M. McDonald +6 more

Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer

The Oncologist(2022)10.1093/oncolo/oyab020

N/A

0DataRank · unranked

30 citations

Nabiel Mir, Mustafa Al‐Obaidi, Deanna Clark, Kelly Kenzik, Andrew M. McDonald +10 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Reducing regorafenib toxicity by combining with dual JAK-HDAC inhibitor in colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e15597

N/A

0DataRank · unranked

0 citations

Sumit Agarwal, Darshan S. Chandrashekar, Amr Elkholy, Hyung Gyoon Kim, Farrukh Afaq +11 more

Study design and methods for the physical activity index (PAI) feasibility pilot trial for breast and colon cancer survivors in North Carolina

Contemporary Clinical Trials Communications(2025)10.1016/j.conctc.2025.101530

N/A

0DataRank · unranked

1 citations

Janet A. Tooze, Joni K. Evans, Jeffrey A. Katula, Kristy Wood, Lesley Hitariansingh +6 more